Dr. Ronald E. Fields, MD
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
7777 Hennessy Blvd Ste 701
Baton Rouge, LA 70808
Who else practices at this address →
East Baton Rouge Parish includes primary care (46% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Louisiana State University School of Medicine in Shreveport (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 531
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: Louisiana State University School of Medicine in Shreveport
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
LA license 023084 -
Pulmonary Disease Physician
LA license 023084 -
Specialist
LA license 023084
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Our Lady of the Lake Regional Medical Center Baton Rouge, LA
- Our Lady of the Angels Hospital Bogalusa, LA
Medical groups
- Our Lady of the Lake Physician Group LLC (644 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 531
- Services billed
- 1,697
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Test to examine how well the lungs exchange gases | 239 | 239 |
| Established patient office or other outpatient visit, 20-29 minutes | 207 | 135 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 201 | 201 |
| Test to determine lung volumes using sensors | 180 | 180 |
| Established patient office or other outpatient visit, 30-39 minutes | 107 | 88 |
| Test to measure expiratory airflow and volume | 96 | 96 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 68 | 36 |
| Test for exercise-induced lung stress | 54 | 54 |
| Test to determine lung volumes using gas dilution or washout | 46 | 46 |
| New patient office or other outpatient visit, 45-59 minutes | 40 | 40 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Baton Rouge, LA | 1,166 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Baton Rouge, LA | 930 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Baton Rouge, LA | 159 |
| Ventolin Hfa (albuterol sulfate) Other prescribers in Baton Rouge, LA | 111 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Baton Rouge, LA | 110 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Baton Rouge, LA | 107 |
| Azithromycin Other prescribers in Baton Rouge, LA | 102 |
| Prednisone Other prescribers in Baton Rouge, LA | 97 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Baton Rouge, LA | 97 |
| Montelukast Sodium Other prescribers in Baton Rouge, LA | 92 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 25 companies reported 139 payments worth $2,858 in total to this clinician.
| GlaxoSmithKline, LLC. | $359 |
|---|---|
| Genzyme Corporation | $359 |
| AstraZeneca Pharmaceuticals LP | $323 |
| Grifols USA, LLC | $237 |
| United Therapeutics Corporation | $207 |
| Verona Pharma, Inc. | $195 |
| Regeneron Healthcare Solutions, Inc. | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $149 |
| Food and Beverage | $2,824 |
|---|---|
| Education | $34.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Aug 22, 2025 | Education in-kind | $34.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.